| __timestamp | Geron Corporation | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1153000 | 9757000 |
| Thursday, January 1, 2015 | 36371000 | 1253000 |
| Friday, January 1, 2016 | 6162000 | 5421000 |
| Sunday, January 1, 2017 | 1065000 | 154584000 |
| Monday, January 1, 2018 | 1066000 | 301034000 |
| Tuesday, January 1, 2019 | 460000 | 380833000 |
| Wednesday, January 1, 2020 | 253000 | 540099000 |
| Friday, January 1, 2021 | 1393000 | 701887000 |
| Saturday, January 1, 2022 | 596000 | 933013000 |
| Sunday, January 1, 2023 | 237000 | 1243336000 |
Unlocking the unknown
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Sarepta Therapeutics, Inc. has emerged as a leader, showcasing a remarkable revenue increase of over 12,000% from 2014 to 2023. Starting with a modest revenue in 2014, Sarepta's financial journey reflects its strategic advancements in genetic medicine, culminating in a staggering $1.24 billion by 2023.
In contrast, Geron Corporation's revenue trajectory tells a different story. Despite a peak in 2015, Geron's revenue has seen a decline, with a 93% drop from its 2015 high to 2023. This divergence highlights the varying fortunes within the biotech sector, where innovation and market adaptation are crucial.
As we look to the future, the question remains: Can Geron pivot to regain its footing, or will Sarepta continue to dominate the revenue landscape?
Breaking Down Revenue Trends: Novo Nordisk A/S vs Geron Corporation
AbbVie Inc. vs Geron Corporation: Examining Key Revenue Metrics
Revenue Insights: Pfizer Inc. and Sarepta Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Revenue Insights: Genmab A/S and Sarepta Therapeutics, Inc. Performance Compared
Incyte Corporation and Geron Corporation: A Comprehensive Revenue Analysis
Who Generates More Revenue? Bio-Techne Corporation or Geron Corporation
Sarepta Therapeutics, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: Sarepta Therapeutics, Inc. vs Perrigo Company plc
Annual Revenue Comparison: Sarepta Therapeutics, Inc. vs Vericel Corporation
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?